Drug profile · INN
sunvozertinib
ZEGFROVY
sunvozertinib (ZEGFROVY) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
Drug details — sunvozertinib
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 5
- Data quality
- 0.84
Quick answer
sunvozertinib (ZEGFROVY) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
Key facts
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
| NMPA | clinical trials | — |
Pipeline programs
Frequently asked questions
What is sunvozertinib?
sunvozertinib (ZEGFROVY) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for sunvozertinib?
ZEGFROVY is a marketed brand name for sunvozertinib. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of sunvozertinib?
sunvozertinib has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.